twitteryou tubeacpRSS Feed

Telecom operator Orange and the Global Fund have signed a partnership deal to develop innovative e-health solutions to reduce the prevalence of AIDS, tuberculosis and malaria in Africa

Using Orange mobile technology, the US$5mn partnership will improve the quality of and access to healthcare via a digital platform that strengthens the link between healthcare professionals and patients.

In association with the Ministry of Health in Morocco - the first country to benefit from the partnership - a digital platform for healthcare professionals will be set up by the end of December to monitor patients with HIV and tuberculosis.

The partnership between the Global Fund and Orange will be extended in 2020 to other African countries including the Côte d’Ivoire, the Democratic Republic of Congo and Burkina Faso.

The digital solutions developed by Orange can also be applied to other e-health fields, including stock management of medication, prevention, and data collection, which is vital to understand and guide healthcare policy.

Bruno Mettling, chairman of Orange Africa and the Middle East, said, “Mobile technology and digital innovations can have a considerable impact on improving the quality of care.”

“We are currently working with the Global Fund and the Ministries of Health to implement innovative m-health platforms that can be used to follow patients remotely while providing healthcare workers with all the information they need to make the right decisions and offer quality healthcare to all patients,” he added.

Peter Sands, executive director of the Global Fund, commented, “I am delighted to see Orange unite with the Global Fund to speed up the fight against these epidemics. Using the enormous potential of mobile technology, our partners in the target countries can reinforce their information systems and ensure broader access to healthcare services.”

“Medical staff can develop more direct links with patients and ensure treatment is followed correctly, which is essential in the fight against HIV, tuberculosis and malaria”, he explained.